Cargando…

Spectral, Anti-Inflammatory, Anti-Pyretic, Leishmanicidal, and Molecular Docking Studies, Against Selected Protein Targets, of a New Bisbenzylisoquinoline Alkaloid

A new bisbenzylisoquinoline named as chondrofolinol (1) and four reported compounds (2–5) were isolated and characterized from the roots of Berberis glaucocarpa Stapf. Anti-inflammatory, anti-pyretic, and leishmanicidal studies were performed against carrageenan-induced paw edema, yeast-induced pyre...

Descripción completa

Detalles Bibliográficos
Autores principales: Alamzeb, Muhammad, Setzer, William N., Ali, Saqib, Khan, Behramand, Rashid, Mamoon-Ur-, Ihsanullah, Salman, Syed Muhammad, Adnan, Omer, Muhammad, Ali, Javed, Ullah, Asad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719521/
https://www.ncbi.nlm.nih.gov/pubmed/34976944
http://dx.doi.org/10.3389/fchem.2021.711190
_version_ 1784624951685283840
author Alamzeb, Muhammad
Setzer, William N.
Ali, Saqib
Khan, Behramand
Rashid, Mamoon-Ur-
Ihsanullah,
Salman, Syed Muhammad
Adnan,
Omer, Muhammad
Ali, Javed
Ullah, Asad
author_facet Alamzeb, Muhammad
Setzer, William N.
Ali, Saqib
Khan, Behramand
Rashid, Mamoon-Ur-
Ihsanullah,
Salman, Syed Muhammad
Adnan,
Omer, Muhammad
Ali, Javed
Ullah, Asad
author_sort Alamzeb, Muhammad
collection PubMed
description A new bisbenzylisoquinoline named as chondrofolinol (1) and four reported compounds (2–5) were isolated and characterized from the roots of Berberis glaucocarpa Stapf. Anti-inflammatory, anti-pyretic, and leishmanicidal studies were performed against carrageenan-induced paw edema, yeast-induced pyrexia, and the promastigotes of Leishmania tropica, respectively. The new compound significantly reduced the paw volume in carrageenan-induced paw edema and rectal temperature in yeast-induced pyrexia at 10 and 20 mg/ kg of body weight. Chondrofolinol caused almost 100% inhibition of the promastigotes of Leishmania tropica. All the compounds displayed minimal cytotoxicity against THP-1 monocytic cells. In order to ascertain the potential macromolecular targets of chondrofolinol responsible for the observed anti-inflammatory and anti-leishmanial activities, a molecular docking study was carried out on relevant protein targets of inflammation and Leishmania. Protein targets of human endoplasmic reticulum aminopeptidase 2 (ERAP2) and human matrix metalloproteinase-1 (MMP-1) for inflammation and protein targets of N-myristoyltransferase (NMT), tyrosyl-tRNA synthetase (TyrRS), and uridine diphosphate-glucose pyrophosphorylase (UGPase) for Leishmania major were selected after thorough literature search about protein targets responsible for inflammation and Leishmania major. Chondrofolinol showed excellent docking to ERAP2 and to MMP-1. The Leishmania major protein targets with the most favorable docking scores to chondrofolinol were NMT, TyrRS, and UGPase. The study indicated that bisbenzylisoquinoline and isoquinoline alkaloids possess anti-pyretic, anti-inflammatory, and anti-leishmanial properties with minimal cytotoxicity and therefore, need to be further explored for their therapeutic potential.
format Online
Article
Text
id pubmed-8719521
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87195212022-01-01 Spectral, Anti-Inflammatory, Anti-Pyretic, Leishmanicidal, and Molecular Docking Studies, Against Selected Protein Targets, of a New Bisbenzylisoquinoline Alkaloid Alamzeb, Muhammad Setzer, William N. Ali, Saqib Khan, Behramand Rashid, Mamoon-Ur- Ihsanullah, Salman, Syed Muhammad Adnan, Omer, Muhammad Ali, Javed Ullah, Asad Front Chem Chemistry A new bisbenzylisoquinoline named as chondrofolinol (1) and four reported compounds (2–5) were isolated and characterized from the roots of Berberis glaucocarpa Stapf. Anti-inflammatory, anti-pyretic, and leishmanicidal studies were performed against carrageenan-induced paw edema, yeast-induced pyrexia, and the promastigotes of Leishmania tropica, respectively. The new compound significantly reduced the paw volume in carrageenan-induced paw edema and rectal temperature in yeast-induced pyrexia at 10 and 20 mg/ kg of body weight. Chondrofolinol caused almost 100% inhibition of the promastigotes of Leishmania tropica. All the compounds displayed minimal cytotoxicity against THP-1 monocytic cells. In order to ascertain the potential macromolecular targets of chondrofolinol responsible for the observed anti-inflammatory and anti-leishmanial activities, a molecular docking study was carried out on relevant protein targets of inflammation and Leishmania. Protein targets of human endoplasmic reticulum aminopeptidase 2 (ERAP2) and human matrix metalloproteinase-1 (MMP-1) for inflammation and protein targets of N-myristoyltransferase (NMT), tyrosyl-tRNA synthetase (TyrRS), and uridine diphosphate-glucose pyrophosphorylase (UGPase) for Leishmania major were selected after thorough literature search about protein targets responsible for inflammation and Leishmania major. Chondrofolinol showed excellent docking to ERAP2 and to MMP-1. The Leishmania major protein targets with the most favorable docking scores to chondrofolinol were NMT, TyrRS, and UGPase. The study indicated that bisbenzylisoquinoline and isoquinoline alkaloids possess anti-pyretic, anti-inflammatory, and anti-leishmanial properties with minimal cytotoxicity and therefore, need to be further explored for their therapeutic potential. Frontiers Media S.A. 2021-12-17 /pmc/articles/PMC8719521/ /pubmed/34976944 http://dx.doi.org/10.3389/fchem.2021.711190 Text en Copyright © 2021 Alamzeb, Setzer, Ali, Khan, Rashid, Ihsanullah, Salman, Adnan, Omer, Ali and Ullah. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Chemistry
Alamzeb, Muhammad
Setzer, William N.
Ali, Saqib
Khan, Behramand
Rashid, Mamoon-Ur-
Ihsanullah,
Salman, Syed Muhammad
Adnan,
Omer, Muhammad
Ali, Javed
Ullah, Asad
Spectral, Anti-Inflammatory, Anti-Pyretic, Leishmanicidal, and Molecular Docking Studies, Against Selected Protein Targets, of a New Bisbenzylisoquinoline Alkaloid
title Spectral, Anti-Inflammatory, Anti-Pyretic, Leishmanicidal, and Molecular Docking Studies, Against Selected Protein Targets, of a New Bisbenzylisoquinoline Alkaloid
title_full Spectral, Anti-Inflammatory, Anti-Pyretic, Leishmanicidal, and Molecular Docking Studies, Against Selected Protein Targets, of a New Bisbenzylisoquinoline Alkaloid
title_fullStr Spectral, Anti-Inflammatory, Anti-Pyretic, Leishmanicidal, and Molecular Docking Studies, Against Selected Protein Targets, of a New Bisbenzylisoquinoline Alkaloid
title_full_unstemmed Spectral, Anti-Inflammatory, Anti-Pyretic, Leishmanicidal, and Molecular Docking Studies, Against Selected Protein Targets, of a New Bisbenzylisoquinoline Alkaloid
title_short Spectral, Anti-Inflammatory, Anti-Pyretic, Leishmanicidal, and Molecular Docking Studies, Against Selected Protein Targets, of a New Bisbenzylisoquinoline Alkaloid
title_sort spectral, anti-inflammatory, anti-pyretic, leishmanicidal, and molecular docking studies, against selected protein targets, of a new bisbenzylisoquinoline alkaloid
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719521/
https://www.ncbi.nlm.nih.gov/pubmed/34976944
http://dx.doi.org/10.3389/fchem.2021.711190
work_keys_str_mv AT alamzebmuhammad spectralantiinflammatoryantipyreticleishmanicidalandmoleculardockingstudiesagainstselectedproteintargetsofanewbisbenzylisoquinolinealkaloid
AT setzerwilliamn spectralantiinflammatoryantipyreticleishmanicidalandmoleculardockingstudiesagainstselectedproteintargetsofanewbisbenzylisoquinolinealkaloid
AT alisaqib spectralantiinflammatoryantipyreticleishmanicidalandmoleculardockingstudiesagainstselectedproteintargetsofanewbisbenzylisoquinolinealkaloid
AT khanbehramand spectralantiinflammatoryantipyreticleishmanicidalandmoleculardockingstudiesagainstselectedproteintargetsofanewbisbenzylisoquinolinealkaloid
AT rashidmamoonur spectralantiinflammatoryantipyreticleishmanicidalandmoleculardockingstudiesagainstselectedproteintargetsofanewbisbenzylisoquinolinealkaloid
AT ihsanullah spectralantiinflammatoryantipyreticleishmanicidalandmoleculardockingstudiesagainstselectedproteintargetsofanewbisbenzylisoquinolinealkaloid
AT salmansyedmuhammad spectralantiinflammatoryantipyreticleishmanicidalandmoleculardockingstudiesagainstselectedproteintargetsofanewbisbenzylisoquinolinealkaloid
AT adnan spectralantiinflammatoryantipyreticleishmanicidalandmoleculardockingstudiesagainstselectedproteintargetsofanewbisbenzylisoquinolinealkaloid
AT omermuhammad spectralantiinflammatoryantipyreticleishmanicidalandmoleculardockingstudiesagainstselectedproteintargetsofanewbisbenzylisoquinolinealkaloid
AT alijaved spectralantiinflammatoryantipyreticleishmanicidalandmoleculardockingstudiesagainstselectedproteintargetsofanewbisbenzylisoquinolinealkaloid
AT ullahasad spectralantiinflammatoryantipyreticleishmanicidalandmoleculardockingstudiesagainstselectedproteintargetsofanewbisbenzylisoquinolinealkaloid